Radioactive tyrosine derivative, method for producing same, labeling agent for positron imaging and medical agent for assessing grade of malignancy of tumor respectively composed of radioactive tyrosine derivative, and method for detecting tumor

US9388122B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9388122-B2
Application numberUS-59755705-A
CountryUS
Kind codeB2
Filing dateMay 25, 2005
Priority dateMay 28, 2004
Publication dateJul 12, 2016
Grant dateJul 12, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

It is intended to provide a radioactive tyrosine derivative represented by the formula (I) or a pharmaceutically acceptable salt thereof: wherein R 1 represents a group selected from the group consisting of — 11 CH 3 , — 11 CH 2 CH 3 , —CH 2 18 F, and —CH 2 CH 2 CH 2 18 F.

First claim

Opening claim text (preview).

The invention claimed is: 1. A radioactive tyrosine derivative represented by the formula (I) or a pharmaceutically acceptable salt thereof: wherein R 1 represents a group selected from the group consisting of — 11 CH 3 , — 11 CH 2 C 3 , —CH 2 18 F, and —CH 2 CH 2 CH 2 18 F.

Assignees

Inventors

Classifications

  • C07C229/36Primary

    with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton · CPC title

  • Organic compounds · CPC title

  • Isotopically modified compounds, e.g. labelled · CPC title

  • Acyclic or carbocyclic compounds · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9388122B2 cover?
It is intended to provide a radioactive tyrosine derivative represented by the formula (I) or a pharmaceutically acceptable salt thereof: wherein R 1 represents a group selected from the group consisting of — 11 CH 3 , — 11 CH 2 CH 3 , —CH 2 18 F, and —CH 2 CH 2 CH 2 18 F.
Who is the assignee on this patent?
Sato Kengo, Tsukada Hideo, Hamamatsu Photonics Kk
What technology area does this patent fall under?
Primary CPC classification C07C229/36. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).